Corrigendum: Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology (Endocrine surgery. 2018;12(4). doi: 10.14341/serg10044)

Abstract

A corrigendum on Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology by Elena E. Stanyakina, Ilia S. Romanov, Tatiana T. Kondratieva, Alexander S. Krylov, Alexey D. Ryzhkov, Sergey V. Shiryaev (2018). Endocrine Surgery. 12(4). doi: 10.14341/serg10044 There is an error on the page 189: "Blood test for hormones: thyroid stimulating hormone (TSH) 52.6mIU/l (reference values 0.254.0), adrenocorticotropic hormone (ACTH) 20IU/ml (030), thyreoglobulin (TG) 0.2ng/ml (030)". Instead of "antibodies to thyroglobulin (ATTG)" was published "adrenocorticotropic hormone (ACTH)". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords

• case report
• medullary thyroid cancer
• screening
• calcitonin
• cytology
• fine-needle aspiration